SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Jan. 22, 2003--Tularik Inc. (Nasdaq:TLRK - News) announced today that it has filed a registration statement with the Securities and Exchange Commission relating to the possible resale of up to approximately 11.4 million shares of Tularik common stock owned by ZKB Pharma Vision AG. This registration statement, once declared effective, would permit Pharma Vision to sell its shares at any time and from time to time in one or more private transactions, underwritten secondary offerings, block trades or otherwise as set forth in the registration statement. Pharma Vision is under no legal obligation to sell any of the shares that are being registered. The timing of any sales under this registration statement will be determined by Pharma Vision, taking into consideration its investment policies as well as market conditions.
A registration statement relating to these securities has been filed with the Securities and Exchange Commission but has not yet become effective. These securities may not be sold nor may offers to buy be accepted prior to the time the registration statement becomes effective. This press release shall not constitute an offer to sell or the solicitation of an offer to buy nor shall there be any sale of these securities in any state in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state.
A prospectus for the offering, when available, may be obtained by contacting Investor Relations at Tularik Inc., Two Corporate Drive, South San Francisco, CA 94080 or by telephone at (650) 825-7000. |
